Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 3Dermatologic 3Thoracic 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Leukemia 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hemoglobinopathies 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 678Cytarabine 576fludarabine 410fludarabine phosphate 387venetoclax 310Methotrexate 297Rituximab 283Azacitidine 264Busulfan 248Whole-Body Irradiation 220Etoposide 215Filgrastim 214Peripheral Blood Stem Cell Transplantation 211Mycophenolic Acid 206Tacrolimus 196Dexamethasone 191Granulocyte Colony-Stimulating Factor 182Vincristine 173Melphalan 173Decitabine 163Cyclosporine 146Daunorubicin 139Antilymphocyte Serum 137Idarubicin 134Imatinib Mesylate 127Lenalidomide 116Doxorubicin 109Radiotherapy 108Stem Cell Transplantation 107Clofarabine 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Photopheresis × Other hematologic neoplasm × Clear all
NCT00179790 2017-03-06

Reduced Intensity Transplant Using Extracorporeal Photopheresis

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1/2 Completed
22 enrolled
Other hematologic neoplasm

Hemoglobinopathies, Immunologic Deficiency Syndromes, Leukemia, Neoplasms

NCT00402714 2017-01-18

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Yale University

Phase 2 Completed
14 enrolled 8 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT01174940 2017-01-09

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

University of Kansas Medical Center

Phase EARLY_PHASE1 Completed
22 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡